Home Medicine Parent observed neuro-behavioral and pro-social improvements with oxytocin following surgical resection of craniopharyngioma
Article
Licensed
Unlicensed Requires Authentication

Parent observed neuro-behavioral and pro-social improvements with oxytocin following surgical resection of craniopharyngioma

  • Naomi Cook , Jennifer Miller EMAIL logo and John Hart
Published/Copyright: May 11, 2016

Abstract

Social and emotional impairment, school dysfunction, and neurobehavioral impairment are highly prevalent in survivors of childhood craniopharyngioma and negatively affect quality of life. As surgical resection of craniopharyngioma typically impairs hypothalamic/pituitary function, it has been postulated that perhaps post-operative deficiency of the hormone oxytocin may be the etiology of social/emotional impairment. Research on the benefits of oxytocin treatment as a hormone facilitating social interaction is well established. However, no research has yet been conducted on patients with known pituitary/hypothalamic dysfunction due to structural lesions or surgery. This case report investigates the effects of oxytocin therapy on a youngster with pituitary/hypothalamic dysfunction after craniopharyngioma removal. In this individual, treatment with low dose intranasal oxytocin resulted in increased desire for socialization and improvement in affection towards family. In light of these findings, the authors believe that further research into the potential benefits of intranasal oxytocin therapy for patients with panhypopituitarism is necessary to determine whether a broader population may also benefit from intranasal oxytocin therapy.


Corresponding author: Jennifer Miller, MD, Department of Pediatrics, University of Florida, Gainesville, FL, USA

Acknowledgments

Gabriel Zada, Department of Neurosurgery, Department of Medicine, Division of Endocrinology, USC Pituitary Center, USA and Justin Seltzer, Keck School of Medicine of USC, Los Angeles, CA, USA.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Poretti A, Grotzer MA, Ribi K, Schönle E, Boltshauser E. Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev Med Child Neurol 2004;46:220–9.10.1111/j.1469-8749.2004.tb00476.xSearch in Google Scholar

2. Müller HL, Gebhardt U, Faldum A, Warmuth-Metz M, Pietsch T, et al. Xanthogranuloma, Rathke’s cyst, and childhood craniopharyngioma: results of prospective multinational studies of children and adolescents with rare sellar malformations. J Clin Endocrinol Metab 2012;97:3935–43.10.1210/jc.2012-2069Search in Google Scholar PubMed

3. Stoop R. Neuromodulation by oxytocin and vasopressin in the central nervous system as a basis for their rapid behavioral effects. Curr Opin Neurobiol 2014;29:187–93.10.1016/j.conb.2014.09.012Search in Google Scholar PubMed

4. Striepens N, Kendrick KM, Hanking V, Landgraf R, Wüllner U, et al. Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans. Sci Rep 2013;3:3440.10.1038/srep03440Search in Google Scholar PubMed PubMed Central

5. Ishak WW, Kahloon M, Fakhry H. Oxytocin role in enhancing well-being: a literature review. J Affect Disord 2011;130:1–9.10.1016/j.jad.2010.06.001Search in Google Scholar PubMed

6. Feldman R, Monakhov M, Pratt M, Ebstein RP. oxytocin pathway genes: evolutionary ancient system impacting on human affiliation, sociality, and psychopathology. Biol Psychiatry 2016;79:174–84.10.1016/j.biopsych.2015.08.008Search in Google Scholar PubMed

7. Yatawara CJ, Einfeld SL, Hickie IB, Davenport TA, Guastella AJ. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial. Mol Psychiatry 2015.10.1038/mp.2015.162Search in Google Scholar PubMed PubMed Central

8. Pedreira CC, Stargatt R, Maroulis H, Rosenfeld J, Maixner W, et al. Health related quality of life and psychological outcome in patients treated for craniopharyngioma in childhood. J Pediatr Endocrinol Metab 2006;19:15–24.10.1515/JPEM.2006.19.1.15Search in Google Scholar PubMed

9. Müller HL. Childhood craniopharyngioma. Pituitary 2013;16:56–67.10.1007/s11102-012-0401-0Search in Google Scholar PubMed

10. Zada G, Kintz N, Pulido M, Amezcua L. Prevalence of neurobehavioral, social, and emotional dysfunction in patients treated for childhood craniopharyngioma: a systematic literature review. PLoS One 2013;8:e76562.10.1371/journal.pone.0076562Search in Google Scholar PubMed PubMed Central

11. Morton GJ, Thatcher BS, Reidelberger RD, Ogimoto K, Wolden-Hanson T, et al. Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats. Am J Physiol Endocrinol Metab 2012;302:E134–44.10.1152/ajpendo.00296.2011Search in Google Scholar PubMed PubMed Central

12. MacDonald E, Dadds MR, Brennan JL, Williams K, Levy F, et al. A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research. Psychoneuroendocrinology 2011;36:1114–26.10.1016/j.psyneuen.2011.02.015Search in Google Scholar PubMed

13. Kosaka H, Munesue T, Ishitobi M, Asano M, Omori M, et al. Long-term oxytocin administration improves social behaviors in a girl with autistic disorder. BMC Psychiatry 2012;12:110.10.1186/1471-244X-12-110Search in Google Scholar PubMed PubMed Central

14. Dolson EP, Conklin HM, Li C, Xiong X, Merchant TE. Predicting behavioral problems in craniopharyngioma survivors after conformal radiation therapy. Pediatr Blood Cancer 2009;52:860–4.10.1002/pbc.21947Search in Google Scholar PubMed PubMed Central

15. Caldwell HK, Albers HE. Oxytocin, Vasopressin, and the motivational forces that drive social behaviors. Horm Behav 2015;75:150–3.10.1007/7854_2015_390Search in Google Scholar PubMed

16. Sobota R, Mihara T, Forrest A, Featherstone RE, Siegel SJ. Oxytocin reduces amygdala activity, increases social interactions, and reduces anxiety-like behavior irrespective of NMDAR antagonism. Behav Neurosci 2015;129:389–98.10.1037/bne0000074Search in Google Scholar PubMed PubMed Central

17. Lancaster K, Carter CS, Pournajafi-Nazarloo H, Karaoli T, Lillard TS, et al. Plasma oxytocin explains individual differences in neural substrates of social perception. Front Hum Neurosci 2015;9:132.10.3389/fnhum.2015.00132Search in Google Scholar PubMed PubMed Central

18. Wirth MM, Gaffey AE, Martinez BS. Effects of intranasal oxytocin on steroid hormones in men and women. Neuropsychobiology 2015;71:202–11.10.1159/000381023Search in Google Scholar PubMed

Received: 2015-11-19
Accepted: 2016-3-29
Published Online: 2016-5-11
Published in Print: 2016-8-1

©2016 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Original Articles
  3. Decreased undercarboxylated osteocalcin in children with type 2 diabetes mellitus
  4. Evaluation of left and right ventricular functions using conventional and tissue Doppler echocardiography in children with type 1 diabetes mellitus
  5. Prevalence of psychosocial morbidity in children with type 1 diabetes mellitus: a survey from Northern India
  6. Increased GLP-1 response to oral glucose in pre-pubertal obese children
  7. Prevalence of idiopathic intracranial hypertension and associated factors in obese children and adolescents
  8. Idiopathic postprandial hyperinsulinaemic hypoglycaemia
  9. Feeding, eating and behavioral disturbances in Prader-Willi syndrome and non-syndromal obesity
  10. Interpretation of thyroid glands in a group of healthy children: real-time ultrasonography elastography study
  11. Ghrelin, insulin-like growth factor I and adipocytokines concentrations in born small for gestational age prepubertal children after the catch-up growth
  12. Zoledronate for Osteogenesis imperfecta: evaluation of safety profile in children
  13. Elevated serum adiponectin is related to elevated serum ferritin and interleukin-6 in β-thalassaemia major children
  14. GCK mutations in Chinese MODY2 patients: a family pedigree report and review of Chinese literature
  15. Cystinosis in Eastern Turkey
  16. Microarray analysis of slipped capital femoral epiphysis growth plates
  17. Case Reports
  18. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: report of three cases from Iran
  19. Type 1 diabetes and GAD65 limbic encephalitis: a case report of a 10-year-old girl
  20. A novel splice site mutation in the GNPTAB gene in an Iranian patient with mucolipidosis II α/β
  21. Parent observed neuro-behavioral and pro-social improvements with oxytocin following surgical resection of craniopharyngioma
  22. A fatal outcome of complicated severe diabetic ketoacidosis in a 11-year-old girl
Downloaded on 18.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2015-0445/html
Scroll to top button